2007
DOI: 10.1016/j.jmmm.2006.11.163
|View full text |Cite
|
Sign up to set email alerts
|

Manipulation of magnetic carriers for drug delivery using pulsed-current high Tc superconductors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Large, single-grain GdBCO-Ag samples [8] and uranium-doped and irradiated YBCO samples have been shown to exhibit maximum trapped fields exceeding 2 T at liquid nitrogen temperature [9]. Such a high flux density with a significant magnetic field gradient could be transformative for a number of promising applications [10], such as portable high-field magnets [11,12], NMR/MRI [13,14], magnetic drug delivery [15,16], superconducting rotating machines [17] and electromagnetic undulators [18].…”
Section: Introductionmentioning
confidence: 99%
“…Large, single-grain GdBCO-Ag samples [8] and uranium-doped and irradiated YBCO samples have been shown to exhibit maximum trapped fields exceeding 2 T at liquid nitrogen temperature [9]. Such a high flux density with a significant magnetic field gradient could be transformative for a number of promising applications [10], such as portable high-field magnets [11,12], NMR/MRI [13,14], magnetic drug delivery [15,16], superconducting rotating machines [17] and electromagnetic undulators [18].…”
Section: Introductionmentioning
confidence: 99%
“…Among all the polysaccharides, CMC is easily available and very cheap. The use of magnetic carriers for delivering drugs and therapy to targeted areas was actively pursued for many years [9][10][11]. This technology allows concentrating drugs in the area of interest, simplifies drug administration procedures, reduces the quantity of drug required to reach therapeutic levels and decreases the concentration of the drug at non-target sites, thus increasing the therapeutic efficacy of the drug and reducing its systemic side-effects [12,13].…”
Section: Introductionmentioning
confidence: 99%